Fetal Smith-Lemli-Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterols

Prenatal Diagnosis

Volumn 18, Issue 7, 1998, Pages 651-658

  Tint, G S ^a,b   Abuelo, Dianne ^c   Till, Marianne ^d   Cordier, M P ^e   Batta, Ashok K ^b   Shefer, Sarah ^b   Honda, Akira ^b   Honda, Megumi ^b   Xu, Guorong ^b   Irons, Mira ^f   Elias, Ellen R ^g   Salen, Gerald ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c BROWN UNIVERSITY   (United States)

^d HÔPITAL DEBROUSSE   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

7 Dehydrocholesterol; Birth defect; Cholesterol biosynthesis; Mental retardation; Metabolic defect

Indexed keywords

7 DEHYDROCHOLESTEROL; CHOLESTEROL;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HIGH RISK PREGNANCY; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SMITH LEMLI OPITZ SYNDROME;

EID: 0031853311     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199807)18:7<651::AID-PD316>3.0.CO;2-V     Document Type: Article

References (41)

1. Abuelo, D., Tint, G.S., Kelley, R., Batta, A.K., Shefer, S., Salen, G. (1995). Prenatal diagnosis of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome by the analysis of amniotic fluid, Am. J. Med. Genet., 56, 281-285.
2. Batta, A.K., Tint, G.S., Abuelo, D., Shefer, S., Salen, G. (1995). Identification of 8-dehydrocholesterol (cholesta-5,8-dien-3β-ol) in patients with Smith-Lemli-Opitz syndrome, J. Lipid Res., 36, 705-713.
3. Belloni, E., Muenke, M., Roessler, E., Traverso, G., Siegel-Bartlet, J., Frumkin, A., Mitchell, H. F., Donis-Keller, H., Helms, C., Hing, A.V., Heng, H.H.Q., Koop, B., Martindale, D., Rommens, J.M., Tsui, L.-C., Scherer, S.W. (1996). Identification of sonic hedgehog as a candidate gene responsible for holoprosencephaly, Nature Genetics, 14, 353-366.
4. Bliss, C.I. (1967). Statistics in Biology, Vol. 1, New York: McGraw-Hill, 199-203.
5. Chiang, C., Ying, L., Lee, E., Young, K.E., Corden, J.L., Westphal, H., Beachy, P.A. (1996). Cyclopia and defective axial patterning in mice lacking sonic hedgehog gene function, Nature, 83, 407-413.
6. Clayton, P., Mills, K., Keeling, J., FitzPatrick, D. (1996). Desmosterolosis: a new inborn error of cholesterol biosynthesis, Lancet, 348, 404.
7. Curry, C.J.R., Carey, J.C., Holland, J.S., Chopra, D., Fineman, R., Golabi, M., Sherman, S., Pagon, R.A., Allanson, J., Shulman, B., Barr, M., McGravey, V., Dabiri, C., Schmike, N., Ives, E., Hall, B.D. (1987). Smith-Lemli-Opitz syndrome - type II: multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality, Am. J. Med. Genet., 26, 45-57.
8. Dallaire, L., Mitchell, G., Giguere, R., Lefebvre, F., Melancon, S.B., Lambert, M. (1995). Prenatal diagnosis of Smith-Lemli-Opitz syndrome is possible by measurement of 7-dehydrocholesterol in amniotic fluid, Prenat. Diagn., 15, 855-858.
9. Dixon, W.J. (Ed.) (1992). BMDP Statistical Software Manual, Vol. 1, Berkely: University of California Press, 585.
10. Gelman-Kohan, Z., Nisani, R., Chemke, J., Appelman, Z., Rappaport, S., Hegesh, E. (1990). Prenatal detection of recurrent SLOS type 2, Am. J. Hum. Genet., 47, A57.
11. Gelman-Kohan, Z., Chemke, J. (1995). Letter to the editor: prenatal diagnosis of SLO syndrome, Am. J. Med. Genet., 56, 288.
12. Guzzetta, V., De Fabiani, E., Galli, G., Colombo, C., Corso, C., Lecora, M., Parenti, G., Strisciuglio, P., Andria, G., The Italian SLOS Collaborative Group (1996). Clinical and biochemical screening for Smith-Lemli-Opitz syndrome, Acta Paediatr., 85, 937-942.
13. Honda, A., Tint, G.S., Salen, G., Batta, A.K., Chen, T.S., Shefer, S. (1995). Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes, J. Lipid Res., 36, 1565-1601.
14. 7-reductase activity in cultured skin fibroblasts utilizing ergosterol as a substrate: a new method for the diagnosis of the Smith-Lemli-Opitz syndrome, J. Lipid Res., 37, 2433-2438.
15. Honda, A., Tint, G.S., Salen, G., Kelley, R.I., Honda, M., Batta, A.K., Chen, T.S., Shefer, S. (1997). Sterol concentrations in cultured Smith-Lemli-Opitz syndrome skin fibroblasts: diagnosis of a biochemically atypical case, Am. J. Med. Genet., 68, 282-287.
16. Irons, M., Elias, E.R., Salen, G., Tint, G.S., Batta, A.K. (1993). Defective cholesterol synthesis in Smith-Lemli-Opitz syndrome, Lancet, 341, 1414.
17. Johnson, J.A., Aughton, D.J., Comstock, C.H., von Oeyen, P.T., Higgins, J.V., Schulz, R. (1994). Prenatal diagnosis of Smith-Lemli-Opitz syndrome, type II, Am. J. Med. Genet., 49, 240-243.
18. Kelley, R.I., Roessler, E., Hennekam, R.C.M., Feldman, G.L., Kosaki, K., Jones, M.C., Palumbos, J.C., Muenke, M. (1996). Holoprosencephaly in RSH/ Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of sonic hedgehog, Am. J. Med. Genet., 66, 478-484.
19. Kelley, R.I. (1995). Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts, Clin. Chim. Acta, 236, 45-58.
20. Lange, Y., Swaisgood, M.H., Ramos, B.V., Steck, T.L. (1989). Plasma membranes contain half the phospholipid and 90 per cent of the cholesterol and sphingomyelin in cultured human fibroblasts, J. Biol. Chem., 264, 3786-3793.
21. Lowry, R.B., Miller, J.R., MacLean, J.R. (1968). Micrognathia, polydactyly, and cleft palate, J. Pediatr., 72, 959-961.
22. Lowry, R.B., Yong, S.-L. (1980). Borderline intelligence in the Smith-Lemli-Opitz syndrome, Am. J. Med. Genet., 1980, 137-143.
23. 7-reductase activity in cultured human fibroblasts: a method for the diagnosis of Smith-Lemli-Opitz syndrome, J. Inher. Metab. Dis., 19, 59-64.
24. McGaughran, J., Donnai, D., Clatyon, P., Mills, K. (1994). Diagnosis of Smith-Lemli-Opitz syndrome. Letter to the Editor, N. Engl. J. Med., 330, 1685-1686.
25. McGaughran, J.M., Clayton, P.T., Mills, S., Rimmer, S., Moore, L., Donnai, D. (1995). Prenatal diagnosis of Smith-Lemli-Opitz syndrome, Am. J. Med. Genet., 56, 269-271.
26. Mills, K., Mandel, H., Montemagno, R., Soothill, P., Gershoni-Baruch, R., Clayton, P. (1996). First trimester prenatal diagnosis of Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency), Pediatr. Res., 39, 816-819.
27. Muenke, M., Hennekam, R.C.M., Kelley, R.I. (1994). Holoprosencephaly as a manifestation in Smith-Lemli-Opitz syndrome, Am. J. Hum. Genet., 55, A35.
28. Norton, W.T., Cammer, W. (1984). Isolation and characterization of myelin. In: Morell, P. (Ed.). Myelin, New York: Plenum Press, 147-195.
29. Nüsslein-Volhard, C., Wieschaus, E. (1980). Mutations affecting segment number and placement in Drosophila, Nature, 287, 795-801.
30. Pober, B. (1990). Smith-Lemli-Opitz syndrome. In: Buyse, M.L. (Ed.). Birth Defects Encyclopedia, Cambridge, MA: Blackwell Scientific Publications, Inc., 1570-1572.
31. Porter, J.A., Ekker, S.C., Park, W.-J., von Kessler, D.P., Young, K.E., Chen, C.-H., Ma, Y., Woods, A.S., Cotter, R.J., Koonin, E.V., Beachy, P.A. (1996a). Hedgehog patterning activity: role of a lipophilic modification mediated by the carboxy-terminal autoprocessing domain, Cell, 86, 21-34.
32. Porter, J.A., Young, K.E., Beachy, P.A. (1996b). Cholesterol modification of hedgehog signaling proteins in animal development, Science, 274, 255-259.
33. Roessler, E., Belloni, E., Gaudenz, K., Jay, P., Berta, P., Scherer, S.W., Tsui, L.-C., Muenke, M. (1996). Mutations in the human sonic hedgehog gene causes holoprosencephaly, Nature Genetics, 14, 357-360.
34. Rossiter, J.P., Hofman, K.J., Kelley, R.I. (1995). Smith-Lemli-Opitz syndrome: prenatal diagnosis by quantification of cholesterol precursors, Am. J. Med. Genet., 56, 272-275.
35. Roux, C. (1964). Action teratogene du triparanol chez l'animal, Arch. Franc. Pediat., 21, 451-464.
36. 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes, J. Clin. Invest., 96, 1779-1785.
37. Smith, D.W., Lemli, L., Opitz, J.M. (1964). A newly recognized syndrome of multiple congenital anomalies, J. Pediatr., 64, 210-217.
38. Stewart, F.J., Nevin, N.C., Dornan, J.C. (1995). Letter to the editor: prenatal diagnosis of Smith-Lemli-Opitz syndrome, Am. J. Med. Genet., 56, 286-287.
39. Tint, G.S., Irons, M., Elias, E.R., Batta, A.K., Frieden, R., Chen, T.S., Salen, G. (1994). Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome, N. Engl. J. Med., 330, 107-113.
40. Tint, G.S., Salen, G., Batta, A.K., Shefer, S., Irons, M., Elias, E., Abuelo, D.N., Johnson, V.P., Lambert, M., Lutz, R., Schanen, C., Morris, C.A., Hoganson, G., Hughes-Benzie, R. (1995a). Correlation of severity and outcome correlate with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome, J. Pediatrics, 127, 82-87.
41. Tint, G.S., Seller, M., Hughes-Benzie, R., Batta, A.K., Shefer, S., Genest, D., Irons, M., Elias, E., Salen, G. (1995b). Markedly increased concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome, J. Lipid Res., 36, 89-95.